Celon Pharma S.A.
WSE:CLN.WA
15.96 (PLN) • At close December 14, 2023
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) PLN.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -28.124 | -36.446 | -15.086 | 21.495 | 11.935 | 29.697 | 25.615 | 37.807 | 37.18 | 52.207 | 17.958 | 1.334 |
| Afschrijvingen & Amortisatie
| 50.016 | 44.095 | 41.342 | 30.882 | 20.621 | 17.214 | 17.261 | 13.352 | 8.166 | 5.15 | 4.319 | 4.339 |
| Uitgestelde Inkomstenbelasting
| 0 | -0.309 | -0.174 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0.309 | 0.174 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| -31.114 | -8.6 | 14.071 | 17.712 | -37.103 | -18.295 | -18.099 | -31.227 | 9.832 | -3.434 | -12.37 | -1.752 |
| Vorderingen
| -12.543 | -6.456 | 13.242 | 2.419 | -5.645 | -6.398 | -6.561 | -6.494 | -0.46 | -9.932 | -3.586 | -1.271 |
| Voorraden
| 11.98 | -15.009 | 6.384 | 0.302 | -6.455 | -5.251 | 1.513 | -0.378 | -13.144 | 2.097 | -5.395 | -0.481 |
| Crediteuren
| -6.948 | 10.244 | -10.174 | 14.489 | -1.575 | 1.784 | 1.164 | 0 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| -23.603 | 2.621 | 4.619 | 0.502 | -23.428 | -13.044 | -19.612 | -30.848 | 22.976 | 4.402 | -3.39 | 0 |
| Overige Niet-Contante Posten
| 0.908 | -3.75 | 3.625 | 0.815 | -0.504 | -0.376 | 0.526 | 0.713 | -2.811 | -29.566 | -1.456 | 7.194 |
| Kasstroom uit Operationele Activiteiten
| -8.314 | -4.701 | 43.952 | 70.904 | -5.051 | 28.24 | 25.303 | 20.646 | 52.368 | 24.358 | 8.45 | 12.867 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -32.813 | -33.906 | -41.352 | -99.163 | -64.952 | -67.46 | -31.34 | -21.287 | -44.861 | -22.546 | -5.642 | -4.343 |
| Netto Overnames
| 0 | 0.587 | 0.171 | 0.631 | -0.01 | 0.342 | 0.24 | -0.5 | 1.115 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | 0 | -79.867 | -46.068 | -0.01 | 0 | 0 | -0.5 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 9.5 | 0 | -0.171 | 45.437 | 0.01 | 0 | 0 | -0.134 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 1.673 | 1.847 | 0.171 | 0.631 | -2.774 | -5.285 | -2.303 | -2.634 | -1.635 | -6.16 | -0.618 | -0.376 |
| Kasstroom uit Investeringsactiviteiten
| -21.64 | -31.472 | -121.048 | -98.532 | -67.736 | -72.745 | -33.644 | -25.055 | -46.496 | -28.707 | -6.259 | -4.719 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| 12.753 | 0 | -12.838 | -4.401 | 0 | 0 | 0 | -1.382 | 0.552 | -0.992 | -2.152 | 0 |
| Uitgifte van Gewone Aandelen
| 0.002 | 0.004 | 216 | 0 | 0 | 0 | 0 | 235.952 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -4.595 | -14.8 | -3.15 | -3.6 | -7.2 | -7.65 | -7.65 | -4.43 | -5.37 | -3.601 | -1.79 | -4.267 |
| Overige Financieringsactiviteiten
| -28.749 | -13.925 | -19.098 | 12.252 | -1.319 | -1.202 | -3.419 | -7.06 | 2.045 | 2.928 | 1.647 | 0.398 |
| Kasstroom uit Financieringsactiviteiten
| -20.589 | -28.721 | 180.914 | 4.914 | -8.519 | -8.852 | -11.069 | 222.394 | -3.15 | -1.666 | -2.296 | -3.869 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -50.543 | -64.894 | 103.818 | -22.714 | -81.305 | -53.357 | -19.41 | 217.985 | 2.723 | -6.015 | -0.105 | 4.278 |
| Kaspositie aan het Einde van de Periode
| 32.359 | 82.902 | 147.796 | 43.978 | 66.692 | 147.998 | 201.355 | 220.765 | 2.78 | 0.057 | 6.072 | 6.177 |